Qube Research & Technologies LTD Vanda Pharmaceuticals Inc. Transaction History

Qube Research & Technologies LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$3.47 - $4.61 $135,215 - $179,637	-38,967 Reduced 9.52%	370,246 $1.52 Million
Q4 2023 Feb 13, 2024	BUY	$3.38 - $4.58 $518,789 - $702,975	153,488 Added 60.02%	409,213 $1.73 Million
Q3 2023 Nov 13, 2023	BUY	$4.28 - $6.57 $1.09 Million - $1.68 Million	255,725 New	255,725 $1.1 Million
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $391,878 - $625,180	57,042 New	57,042 $421,000
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $281,478 - $357,970	-30,234 Reduced 34.33%	57,842 $630,000
Q1 2022 May 09, 2022	BUY	$10.84 - $16.55 $79,099 - $120,765	7,297 Added 9.03%	88,076 $996,000
Q4 2021 Feb 01, 2022	BUY	$15.69 - $21.14 $1.27 Million - $1.71 Million	80,779 New	80,779 $1.27 Million
Q2 2021 Aug 13, 2021	SELL	$15.71 - $21.51 $1.02 Million - $1.4 Million	-64,980 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$13.42 - $20.28 $652,963 - $986,743	48,656 Added 298.06%	64,980 $976,000
Q4 2020 Feb 16, 2021	BUY	$9.77 - $13.81 $6,545 - $9,252	670 Added 4.28%	16,324 $214,000
Q3 2020 Nov 12, 2020	BUY	$9.32 - $12.02 $145,895 - $188,161	15,654 New	15,654 $151,000
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $90,270 - $202,204	-12,036 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$12.38 - $17.47 $149,005 - $210,268	12,036 New	12,036 $198,000

157

44.9M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.